April 14, 2026 Mark Hobraczk, legislative lead for the EACH/PIC Coalition, issued the following statement in response to Governor Abigail Spanberger issuing an amendment in the nature of a substitute […]
The EACH/PIC Coalition submitted a letter to the Illinois House Health Care Availability and Accessibility Committee urging opposition or further amendments to the updated version of HB 1443. The letter
April 14, 2026 Tiffany Westrich-Robertson, EACH/PIC Coalition founder and person living with an autoimmune condition, issued the following statement on the Maryland Prescription Drug Affordability Board vote on implementing an
The EACH/PIC Coalition submitted comments to the Oregon PDAB in providing input into the 2026 cost review process. The letter stated: “We appreciate the opportunity to provide comments as the
The EACH/PIC Coalition submitted a letter to the Senate Insurance Committee opposing passage of SB 401, which would create a Prescription Drug Affordability Board (PDAB), and SB 369, which would
The EACH/PIC Coalition submitted a letter to the Rhode Island Senate Committee on Health and Human Services. The letter urged the committee to oppose legislation that would adopt Medicare’s maximum
The EACH/PIC Coalition submitted a letter to the Illinois House Health Care Availability and Accessibility Committee opposing passage of HB 1443, which would create a Prescription Drug Affordability Board (PDAB)
New Patient-Led Research Finds Insurance Barriers and Cost Instability Are Primary Drivers of Patient Prescription Drug Affordability Challenges EACH/PIC Urges Policymakers to Rethink Policies that Risk Worsening Access and Focus
The EACH/PIC Coalition submitted letters to Prescription Drug Affordability Boards in seven states, sharing the findings from the Patient Experience Project: Patient-Reported Affordability & Unaffordability Survey 2.0. Letters were submitted
The EACH/PIC Coalition submitted a comment letter to the Maryland PDAB, providing input on the board’s ongoing drug reviews. The letter stated: “We appreciate the opportunity to submit comments as
